Home
Categories
Pharmaceutical
Hi Tech Manufacturing
Food
Finance
Company News
Design & Build
Containment
Cleaning
Sustainability
HVAC
Personal Protection
Regulatory
CT CONFERENCE
Events
Directory
Editorial team
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Market Reports
Standardising pharmaceutical sustainability: Speaking to the creators of BSI PAS 2090?
Courtney Soulsby, Sector Development Director at BSI, and Daniel Witte, Director of Corporate Sustainability at the standard’s co-sponsor and project management office, SLR Consulting, discuss their work standardising sustainability reporting and reduce “greenwashing”
What is RMM?
RMM, or Rapid Microbial Methods, is a concept that is the future of cleanroom monitoring, but what is it and what technologies are out there?
What is happening with the cleanroom market in the United States?
Sophie Bullimore looks at some of the major trends and changes taking place in the US cleanroom market in the last year
Choosing a location to build a data centre or fab
Katie Coulson from Skanska Advanced Technology discusses the process by which data centre and fab locations are chosen
Are centralised and de-centralised approaches to CGT manufacturing really that different?
Andrew Scheffler from ScaleReady discusses whether CGT manufacturing should be centralised in large, industrial facilities, or decentralised closer to the patient in hospital-based or regional sites
Skanska's VP Kate Coulson on the company's technology division launch
The VP leading Skanska’s newly launched advanced technology division talks to Sophie Bullimore about the launch and the market landscape that has defined it
Cleanroom Technology Conference 2026: A review of the highlights
Attendees from Lonza, the NHS, ITH Pharma, Guardtech, AstraZeneca, Kingspan and more, have attended a two day event in Birmingham for the cleanroom and contamination control sector
When are isolators or RABS essential rather than optional?
The new EU GMP Annex 1 clearly stipulates that the absence of a barrier system must be thoroughly justified, but when is this, and what does it mean for isolator configuration, automation, glove handling, cleaning processes, and decontamination methods? Dr. Timo Krebsbach and Dipl.-Ing. Frank Lehmann from SKAN answer this and more
How to design your pharmaceutical facility disinfection programme: Development, validation, and implementation
The development, validation, and implementation of a robust disinfection programme are critical components of Good Manufacturing Practices (GMP). James Polarine, Matt Hofacre and Tony Cundell explain what you need to do
Pharmaceutical waste: What do I do with it?
Emma Cooke from Envirovue discusses the many hazardous elements of pharmaceutical waste and the importance of effective management and compliance
Pharma sector uses AI agents to reduce IT incident response times, says KTSL
Aaron Perrott, CTO at KTSL, explains how pharmaceutical companies are using AI agents to improve IT response times, reduce MTTR and support faster clinical and operational workflows
Cleanroom compatibility of wafers: Practical guidance on selecting the right analysis methods
Technical Account Manager Kalle Niiranen from Measurlabs reviews key techniques for confirming that wafer surfaces do not carry contaminants that could compromise cleanroom integrity
Advanced therapy production: A real-world business case for an open RABS upgrade in aseptic production
Thierry Bettinger, R&D Director from Bracco, explains the company’s rationale behind upgrading its Geneva pilot plant with an open Restricted Access Barrier System (RABS) ahead of BubbleGen product line launch
“Operationally net-zero cleanroom laundry”: The details on the £20m project as of now
Sophie Bullimore talks to Micronclean Directors, Greg Cochran and Sophie Harris, about the company’s recent £20m project
Development, validation, and implementation: How to design your pharmaceutical facility disinfection programme
The development, validation, and implementation of a robust disinfection programme are critical components of Good Manufacturing Practices (GMP). James Polarine, Matt Hofacre and Tony Cundell explain what you need to do
Wolfgang Hassa from ReinraumZelt on the "cleanroom tent" concept
The founder of Germany-based “Cleanroom Tent”, Wolfgang Hassa, speaks to Sophie Bullimore about what applications a cleanroom tent is ideal for, how they work, and dives into the company’s rental model
Previous
1
2
(current)
3
4
5
6
7
…
29
Next
Trending Articles
Challenging disinfectant residues as per GMP Annex 1
Karen Rossington of Contec analyses commonly used cleanroom disinfectants to shed light on the best approach to tackle residues that are left on surfaces
Choosing doors for food processing facilities
Sheree Headspith of Dortek walks through the qualities and requirements for selecting the right set of doors for food processing areas
Continuous cleanroom monitoring: A look at automated settle plate handling
Continuous monitoring is becoming increasingly important in the most critical areas like class A and B of aseptic manufacturing or ATMP production, Miriam Schönenberger and Florian Blum from MVB discuss how it can be implemented in the best possible way
GMP Annex 1: Validation of disinfectants on cleanroom surfaces
Published in August 2022, for implementation in August 2023, Karen Rossington from Contec looks at the revised version of EU GMP Annex 1 expanded and clarified the regulatory requirements of cleaning and disinfection in life science cleanrooms
You need to be a subscriber to read this article.
Click here
to find out more.
Annex 1 and “first air”: What is it and how is it used?
First Air as a concept is a major update in the new Annex 1 to continue global harmonisation of regulatory standards, but what is it and how is it used in the new document to improve clarity and compliance? Josh Russell, VP of Sales and Marketing at AST discusses
Upcoming event
ContaminExpo
16–17 September 2026 | Expo | National Exhibition Centre
See all